Wertz D C, Fletcher J C
Health Services Section, Boston University School of Public Health, MA 02118.
Public Health Rep. 1989 Jan-Feb;104(1):35-44.
A survey on mass screening was sent to 1,053 medical geneticists in 18 nations, of whom 677 responded. Three theoretical screening situations were proposed, screening in the workplace for genetic susceptibility to work-related disease, carrier screening for cystic fibrosis, and presymptomatic testing for Huntington disease. Of the respondents, 72 percent thought screening in the workplace should be voluntary, and 81 percent said employers should have no access without the worker's consent, including 22 percent who believed that employers should have no access at all. There was strong consensus in all but one nation that insurance companies should have no access to test results without the worker's consent, and strong consensus in two countries that they should have no access at all. Most (82 percent) believed that screening for cystic fibrosis should be applied to the entire population, but 18 percent believed that it should be applied primarily to Caucasians. In all, 66 percent of respondents believed that individuals at risk for Huntington disease should be told their test results only if they say that they wish to know, recognizing a "right not to know" whether they will develop the disease in later life. Twelve percent thought that spouses should have access to test results if they asked, and 26 percent thought that spouses should be informed of results even if they did not ask. Geneticists in all nations were vividly aware of the potential damage from third party access to results, especially access by insurance companies. They had little sympathy with insurers' needs to assess actuarially accurate premiums.
一项关于大规模筛查的调查被发送给了18个国家的1053名医学遗传学家,其中677人进行了回复。提出了三种理论上的筛查情况:在工作场所对与工作相关疾病的遗传易感性进行筛查、对囊性纤维化进行携带者筛查以及对亨廷顿病进行症状前检测。在受访者中,72%的人认为在工作场所进行筛查应该是自愿的,81%的人表示未经工人同意雇主不应获取相关信息,其中22%的人认为雇主根本不应获取。除一个国家外,在所有国家都存在强烈共识,即未经工人同意保险公司不应获取检测结果,在两个国家存在强烈共识,即保险公司根本不应获取。大多数(82%)人认为对囊性纤维化的筛查应适用于全体人群,但18%的人认为应主要适用于白种人。总体而言,66%的受访者认为只有当有亨廷顿病风险的个体表示希望知道时才应告知其检测结果,即承认他们有“不知道”自己晚年是否会患病的“权利”。12%的人认为如果配偶询问,他们应该能够获取检测结果,26%的人认为即使配偶没有询问也应告知其结果。所有国家的遗传学家都清楚地意识到第三方获取检测结果可能造成的潜在损害,尤其是保险公司获取结果。他们对保险公司评估精确保险费的需求几乎没有同情。